Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
|
+$596M |
| 2 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$429M |
| 3 |
Verizon
VZ
|
+$399M |
| 4 |
Amgen
AMGN
|
+$214M |
| 5 |
Citizens Financial Group
CFG
|
+$212M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MBS ETF
MBB
|
+$561M |
| 2 |
iShares National Muni Bond ETF
MUB
|
+$535M |
| 3 |
Oracle
ORCL
|
+$144M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$143M |
| 5 |
Vanguard Mortgage-Backed Securities ETF
VMBS
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.17% |
| 2 | Financials | 13.07% |
| 3 | Healthcare | 12.05% |
| 4 | Consumer Discretionary | 10.98% |
| 5 | Industrials | 9.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3126
Smith Micro Software
SMSI
$13.9M
| $566K | ﹤0.01% |
2,708
+572
| +27% | +$122K |
|
3127
Arbutus Biopharma
ABUS
$871M
| $565K | ﹤0.01% |
186,468
+165,556
| +792% | +$513K |
|
3128
Ceco Environmental
CECO
$3.83B
| $565K | ﹤0.01% |
78,841
-342
| -0.4% | -$2.65K |
|
|
BCEL
3129
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $564K | ﹤0.01% |
66,197
-6,755
| -9% | -$69.2K |
|
|
REV
3130
DELISTED
Revlon, Inc.
REV
| $564K | ﹤0.01% |
43,878
+831
| +2% | +$10.4K |
|
|
USX
3131
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
| $563K | ﹤0.01% |
65,380
+10,169
| +18% | +$108K |
|
3132
Heritage Insurance Holdings
HRTG
$907M
| $557K | ﹤0.01% |
64,889
+2,761
| +4% | +$25.4K |
|
3133
Vale
VALE
$63.8B
| $556K | ﹤0.01% |
24,337
-2,930
| -11% | -$61.3K |
|
3134
SAP
SAP
$209B
| $554K | ﹤0.01% |
3,944
+944
| +31% | +$131K |
|
3135
Solid Biosciences
SLDB
$836M
| $553K | ﹤0.01% |
10,062
+5,283
| +111% | +$349K |
|
3136
Fidelity D&D Bancorp
FDBC
$305M
| $552K | ﹤0.01% |
10,199
| – | – |
|
3137
Atlanticus Holdings
ATLC
$1.6B
| $549K | ﹤0.01% |
13,823
+861
| +7% | +$30.1K |
|
|
CCRD
3138
DELISTED
CoreCard
CCRD
| $549K | ﹤0.01% |
17,438
-1,046
| -6% | -$37.3K |
|
3139
Outlook Therapeutics
OTLK
$194M
| $548K | ﹤0.01% |
11,003
+9,281
| +539% | +$431K |
|
3140
Biodesix
BDSX
$221M
| $547K | ﹤0.01% |
2,067
+910
| +79% | +$286K |
|
3141
The ONE Group
STKS
$56.5M
| $547K | ﹤0.01% |
+49,621
| New | +$503K |
|
|
PSTL
3142
Postal Realty Trust
PSTL
$694M
| $543K | ﹤0.01% |
+29,726
| New | +$579K |
|
3143
Mayville Engineering Co
MEC
$660M
| $540K | ﹤0.01% |
26,814
+3,398
| +15% | +$60K |
|
|
VOXX
3144
DELISTED
VOXX International Corporation Class A
VOXX
| $540K | ﹤0.01% |
38,522
-9,084
| -19% | -$147K |
|
|
PFBI
3145
DELISTED
Premier Financial Bancorp
PFBI
| $540K | ﹤0.01% |
31,989
-1,852
| -5% | -$34.3K |
|
|
SOLY
3146
DELISTED
Soliton, Inc.
SOLY
| $539K | ﹤0.01% |
23,935
+4,051
| +20% | +$81.9K |
|
3147
Concrete Pumping Holdings
BBCP
$496M
| $538K | ﹤0.01% |
63,458
| – | – |
|
|
URG
3148
Ur-Energy
URG
$497M
| $538K | ﹤0.01% |
+383,722
| New | +$524K |
|
|
FTH
3149
Faeth Therapeutics
FTH
$743M
| $537K | ﹤0.01% |
2,748
+436
| +19% | +$108K |
|
3150
First Bank
FRBA
$462M
| $536K | ﹤0.01% |
39,524
-2,638
| -6% | -$34.2K |
|
Similar funds
Charles Schwab's Q2 2021 Portfolio in Review
As of Q2 2021, Charles Schwab held 3,648 positions worth $301B, up 10% from $273B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2021 filing shows 163 new, 2,481 increased, 676 reduced and 240 closed positions. Its largest new stake was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M. The largest sale was iShares MBS ETF, an estimated $561M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2021 buy was Vanguard Intermediate-Term Treasury ETF: 6,338,757 shares worth $430M.
- Charles Schwab added most to iShares 1-5 Year Investment Grade Corporate Bond ETF in Q2 2021, an estimated $596M increase.
- Charles Schwab's biggest Q2 2021 reduction was iShares MBS ETF, cutting an estimated $561M.
- Charles Schwab fully exited Invesco S&P 500 Low Volatility ETF in Q2 2021, selling an estimated $92.7M.
- Charles Schwab's ten largest holdings make up 17% of its $301B portfolio in Q2 2021.
- Charles Schwab opened 163 new positions and closed 240 in Q2 2021.
- Charles Schwab's portfolio value rose 10% quarter-over-quarter to $301B.
Based on Charles Schwab's 13F filing for Q2 2021, filed 16 Aug 2021.